ObjectiveTo conduct a proof-of-concept study comparing Lorenz-curve analysis (LCA) with power-law (exponential function) analysis (PLA), by applying segmented regression modeling to 1-year prescription claims data for three medications—alprazolam, opioids, and gabapentin—to predict abuse and/or diversion using power-law zone (PLZ) classification.ResultsIn 1-year baseline...
& Kathleen A. Fairman Background Among US adults, utilization of pharmacotherapy for attention-deficit hyperactivity disorder (ADHD) has increased more than ninefold since 1995-1996. Potential
Real-world use of PCSK-9 inhibitors by early adopters: cardiovascular risk factors, statin co-treatment, and short-term adherence in routine clinical practice Kathleen A Fairman, Lindsay E Davis ... cost of cardiovascular events. Disclosure Kathleen A Fairman discloses that she is a health outcomes research consultant whose analyses include assessments lfdeoadn rrspeoF w o d t n e m e g a n a M k
Peckham, Kathleen A Fairman, David A Sclar Department of Pharmacy Practice, Midwestern University College of Pharmacy – Glendale, Glendale, AZ, USA Background: The prevalence of comorbid depression in
Cathryn A Carroll Kathleen A Fairman Maureen J Lage Background: For patients with multiple sclerosis (MS), previous research identified key disease sequelae as important cost drivers and suggested